These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

501 related articles for article (PubMed ID: 1319311)

  • 1. Itraconazole in neutropenic patients.
    van't Wout JW
    Chemotherapy; 1992; 38 Suppl 1():23-6. PubMed ID: 1319311
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Therapy of systemic mycoses in neutropenic patients using itraconazole. A comparative, randomized study with amphotericin B].
    van't Wout JW; Novakova I; Verhagen CA; Fibbe WE; de Pauw BE; van der Meer JW
    Med Klin (Munich); 1991 Dec; 86 Suppl 1():11-3. PubMed ID: 1663200
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The efficacy of itraconazole against systemic fungal infections in neutropenic patients: a randomised comparative study with amphotericin B.
    van't Wout JW; Novakova I; Verhagen CA; Fibbe WE; de Pauw BE; van der Meer JW
    J Infect; 1991 Jan; 22(1):45-52. PubMed ID: 1848268
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Prophylaxis against mycoses in neutropenic patients].
    Arning M; Aul C
    Mycoses; 1994; 37 Suppl 2():70-6. PubMed ID: 7541892
    [TBL] [Abstract][Full Text] [Related]  

  • 5. In vitro antifungal spectrum of itraconazole and treatment of systemic mycoses with old and new antimycotic agents.
    Van Cutsem J
    Chemotherapy; 1992; 38 Suppl 1():3-11. PubMed ID: 1319313
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison of the efficacies of amphotericin B, fluconazole, and itraconazole against a systemic Candida albicans infection in normal and neutropenic mice.
    Van t Wout JW; Mattie H; van Furth R
    Antimicrob Agents Chemother; 1989 Feb; 33(2):147-51. PubMed ID: 2541654
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antifungal prophylaxis with itraconazole oral solution in neutropenic patients.
    Kibbler CC
    Mycoses; 1999; 42 Suppl 2():121-4. PubMed ID: 10865918
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Itraconazole is not effective for the prophylaxis of fungal infections in patients with neutropenia.
    Kaptan K; Ural AU; Cetin T; Avcu F; Beyan C; Yalçin A
    J Infect Chemother; 2003 Mar; 9(1):40-5. PubMed ID: 12673406
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Itraconazole oral solution for primary prophylaxis of fungal infections in patients with hematological malignancy and profound neutropenia: a randomized, double-blind, double-placebo, multicenter trial comparing itraconazole and amphotericin B.
    Harousseau JL; Dekker AW; Stamatoullas-Bastard A; Fassas A; Linkesch W; Gouveia J; De Bock R; Rovira M; Seifert WF; Joosen H; Peeters M; De Beule K
    Antimicrob Agents Chemother; 2000 Jul; 44(7):1887-93. PubMed ID: 10858349
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Safety and efficacy of itraconazole in prevention of fungal infections in neutropenic patients.
    Thunnissen PL; Sizoo W; Hendriks WD
    Neth J Med; 1991 Aug; 39(1-2):84-91. PubMed ID: 1660108
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Therapy for fungal infections in leukemia.
    Segal RE; Minamoto GY
    Curr Oncol Rep; 2001 May; 3(3):201-8. PubMed ID: 11296129
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Fungal colonization in neutropenic patients: a randomized study comparing itraconazole solution and amphotericin B solution.
    Lass-Flörl C; Gunsilius E; Gastl G; Englisch M; Koch G; Ulmer H; Dierich MP; Petzer A
    Ann Hematol; 2003 Sep; 82(9):565-9. PubMed ID: 14504812
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Itraconazole versus amphotericin B plus nystatin in the prophylaxis of fungal infections in neutropenic cancer patients.
    Boogaerts M; Maertens J; van Hoof A; de Bock R; Fillet G; Peetermans M; Selleslag D; Vandercam B; Vandewoude K; Zachée P; De Beule K
    J Antimicrob Chemother; 2001 Jul; 48(1):97-103. PubMed ID: 11418517
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Management of mycoses in surgical patients -- review of the literature.
    Holzheimer RG; Dralle H
    Eur J Med Res; 2002 May; 7(5):200-26. PubMed ID: 12069912
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Fungal complications of transplantation: diagnosis, treatment and prevention.
    Warnock DW
    J Antimicrob Chemother; 1995 Oct; 36 Suppl B():73-90. PubMed ID: 8601545
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Strategies for managing systemic fungal infection and the place of itraconazole.
    Potter M
    J Antimicrob Chemother; 2005 Sep; 56 Suppl 1():i49-i54. PubMed ID: 16120634
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A multicenter, randomized trial of fluconazole versus amphotericin B for empiric antifungal therapy of febrile neutropenic patients with cancer.
    Winston DJ; Hathorn JW; Schuster MG; Schiller GJ; Territo MC
    Am J Med; 2000 Mar; 108(4):282-9. PubMed ID: 11014720
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Itraconazole prophylaxis for invasive gingival aspergillosis in neutropenic patients with acute leukemia.
    Myoken Y; Sugata T; Kyo T; Fujihara M; Mikami Y
    J Periodontol; 2002 Jan; 73(1):33-8. PubMed ID: 11846198
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Systemic mycotic infections].
    Meunier F
    Recenti Prog Med; 1990 Jan; 81(1):18-22. PubMed ID: 2173078
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Itraconazole versus ketoconazole for the prophylaxis of fungal infection in neutropenic children: results of two consecutive nonrandomized studies.
    Ninane J; Sluysmans T; Vermylen C; De Beule K; Woestenborghs R; Cauwenbergh G; Cornu G
    Pediatr Hematol Oncol; 1989; 6(4):349-53. PubMed ID: 2561916
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 26.